논문KCI 등재
The utility of ezetimibe therapy in nonalcoholic fatty liver disease
2
조회
0
다운로드
0
인용
0
참고문헌
주제분류내과학
참고문헌 (13)
- Loomba R, "The global NAFLD epidemic", Nat Rev Gastroenterol Hepatol, 10, pp.686~690 (2013)
- Pais R, "A systematic review of follow-up biopsies reveals disease progression in patients with non-alcoholic fatty liver", J Hepatol, 59, pp.550~556 (2013)
- Souza MR, "Metabolic syndrome and risk factors for non-alcoholic fatty liver disease", Arq Gastroenterol, 49, pp.89~96 (2012)
- Filippatos TD, "Lipid-lowering drugs acting at the level of the gastrointestinal tract", Curr Pharm Des, 15, pp.490~516 (2009)
- Muraoka T, "Ezetimibe decreases SREBP-1c expression in liver and reverses hepatic insulin resistance in mice fed a high-fat diet", Metabolism, 60, pp.617~628 (2011)
- 이효영, "Ezetimibe decreased nonalcoholic fatty liver disease activity score but not hepatic steatosis", The Korean Journal of Internal Medicine, 34(2), pp.296~304 (2019), 대한내과학회[DOI]
- Takeshita Y, "The effects of ezetimibe on non-alcoholic fatty liver disease and glucose metabolism : a randomised controlled trial", Diabetologia, 57, pp.878~890 (2014)
- Nakade Y, "Ezetimibe for the treatment of non-alcoholic fatty liver disease : a meta-analysis", Hepatol Res, 47, pp.1417~1428 (2017)
- Simon TG, "The nonalcoholic fatty liver disease(NAFLD)fibrosis score, cardiovascular risk stratification and a strategy for secondary prevention with ezetimibe", Int J Cardiol, 270, pp.245~252 (2018)
- Loomba R, "Ezetimibe for the treatment of nonalcoholic steatohepatitis : assessment by novel magnetic resonance imaging and magnetic resonance elastography in a randomized trial(MOZART trial)", Hepatology, 61, pp.1239~1250 (2015)
- Kim SH, "Ezetimibe ameliorates steatohepatitis via AMP activated protein kinase-TFEB-mediated activation of autophagy and NLRP3inflammasome inhibition", Autophagy, 13, pp.1767~1781 (2017)
- Erqou S, "Statins and glycaemic control in individuals with diabetes : a systematic review and meta-analysis", Diabetologia, 57, pp.2444~2452 (2014)
- Wu H, "Effect of ezetimibe on glycemic control : a systematic review and meta-analysis of randomized controlled trials", Endocrine, 60, pp.229~239 (2018)
관련 논문AI추천
Ezetimibe decreased nonalcoholic fatty liver disease activity score but not hepatic steatosis김현정, 안형식, 오현우, 이효영, 전대원, Mindie H. Nguyen, Ramsey C. Cheung, Waqar Khalid Saeed대한내과학회 · The Korean Journal of Internal Medicine2019 · 제34권 제2호Recent updates on pharmacologic therapy in nonalcoholic fatty liver diseaseJae Young Jang, Soung Won Jeong, Young Chang대한간학회 · Clinical and Molecular Hepatology2024 · 제30권 제1호Personalized medicine in nonalcoholic fatty liver diseaseCarlos J. Pirola, Silvia Sookoian대한간학회 · Clinical and Molecular Hepatology2022 · 제28권 제4호Effect of Non-Statin Lipid-Lowering Therapy on Hepatic Outcomes in Metabolic Dysfunction-Associated Steatotic Liver Disease and Steatohepatitis: A Systematic ReviewBarbagelata Leandro, Masson Walter, Nogueira Juan Patricio한국지질동맥경화학회 · 지질·동맥경화학회지2025 · 제14권 제3호Implications of comorbidities in nonalcoholic fatty liver diseaseSherlot Juan Song, Vincent Wai-Sun Wong대한간학회 · Clinical and Molecular Hepatology2023 · 제29권 제2호Non-invasive biomarkers of liver fibrosis in non-alcoholic fatty liver diseaseMaamon Basheer, Mohamed Naffaa, Nimer Assy대한간학회 · Clinical and Molecular Hepatology2023 · 제29권 제2호
이 간행물의 다른 논문 (27건)
Endoscopy training in Korea김병욱, 김준성pp. 237-241Recent advances in the diagnosis and management of chronic pancreatitisGlen A. Lehman, Mark A. Gromski, 최성훈, 조재희, 고광현, Temel Tirkes, 권창일pp. 242-260Endoscopic management of anastomotic stricture after living-donor liver transplantation이동욱, 한지민pp. 261-268Chronic venous insufficiency and varicose veins of the lower extremities이주영, 윤영진pp. 269-283Fluoroquinolone resistance in multidrug-resistant tuberculosis patients이현우, 임재준pp. 286-287
